PL3030319T3 - Kompozycje zawierające pochodne witaminy k i sole - Google Patents

Kompozycje zawierające pochodne witaminy k i sole

Info

Publication number
PL3030319T3
PL3030319T3 PL14747668T PL14747668T PL3030319T3 PL 3030319 T3 PL3030319 T3 PL 3030319T3 PL 14747668 T PL14747668 T PL 14747668T PL 14747668 T PL14747668 T PL 14747668T PL 3030319 T3 PL3030319 T3 PL 3030319T3
Authority
PL
Poland
Prior art keywords
vitamin
derivatives
salts
compositions
Prior art date
Application number
PL14747668T
Other languages
English (en)
Inventor
Inger Reidun Aukrust
Mona Møller
Original Assignee
Kappa Bioscience As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kappa Bioscience As filed Critical Kappa Bioscience As
Publication of PL3030319T3 publication Critical patent/PL3030319T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL14747668T 2013-08-08 2014-08-06 Kompozycje zawierające pochodne witaminy k i sole PL3030319T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1314245.0A GB201314245D0 (en) 2013-08-08 2013-08-08 Provitamins
PCT/EP2014/066886 WO2015018858A1 (en) 2013-08-08 2014-08-06 Compositions comprising vitamin k derivatives and salts
EP14747668.3A EP3030319B1 (en) 2013-08-08 2014-08-06 Compositions comprising vitamin k derivatives and salts

Publications (1)

Publication Number Publication Date
PL3030319T3 true PL3030319T3 (pl) 2018-10-31

Family

ID=49261912

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14747668T PL3030319T3 (pl) 2013-08-08 2014-08-06 Kompozycje zawierające pochodne witaminy k i sole

Country Status (9)

Country Link
US (1) US20160184254A1 (pl)
EP (1) EP3030319B1 (pl)
CN (1) CN105492073B (pl)
AU (1) AU2014304510B2 (pl)
DK (1) DK3030319T3 (pl)
GB (1) GB201314245D0 (pl)
HU (1) HUE038719T2 (pl)
PL (1) PL3030319T3 (pl)
WO (1) WO2015018858A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3801477A4 (en) 2018-06-08 2022-02-23 Epizon Pharma, Inc. METHODS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF TISSUE CALCIFICATION
CA3102979A1 (en) 2018-06-08 2019-12-12 Epizon Pharma, Inc. Methods and compositions for preventing or treating calciphylaxis
CA3111108A1 (en) 2018-09-12 2020-03-19 Epizon Pharma, Inc. Menaquinol compositions and methods of treatment
JP7394433B2 (ja) * 2019-03-19 2023-12-08 学校法人福岡大学 光曝露下に適用されるビタミンｋ剤及びそれを用いた皮膚外用剤、点眼剤、眼軟膏剤
CN115427027B (zh) * 2020-03-17 2024-12-10 滨特劳工公司 线粒体功能障碍改善剂
WO2023119230A1 (en) 2021-12-22 2023-06-29 L'oreal Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2456686A (en) * 1944-05-11 1948-12-21 President & Board Of Trustees Process for obtaining vitamink compounds
GB893172A (en) * 1959-10-20 1962-04-04 Roche Products Ltd A process for the manufacture of phosphoric acid esters and novel phosphoric acid esters
CH575904A5 (pl) * 1972-02-16 1976-05-31 Eisai Co Ltd
US20050090553A1 (en) * 1992-06-30 2005-04-28 Shapiro Howard K. Compositions and method for treatment of chronic inflammatory diseases
JPH1035256A (ja) * 1996-07-18 1998-02-10 Denso Corp 車両用暖房装置
JP3459932B2 (ja) * 1996-07-23 2003-10-27 株式会社ホーネンコーポレーション 抗骨粗鬆症組成物
DE19964116A1 (de) * 1999-12-30 2001-07-05 Liebscher Dierck H Verfahren zur Erhöhung der Bioverfügbarkeit von Magnesiumionen im Organismus sowie eine pharmazeutische Verpackungseinheit auf dieser Basis
JP4040082B2 (ja) * 2005-01-28 2008-01-30 学校法人福岡大学 ビタミンｋヒドロキノン誘導体を用いる癌治療剤および再発予防剤
US20080220094A1 (en) * 2006-11-01 2008-09-11 Wyeth Compositions and methods for the treatment and/or prevention of osteoporosis
EP2575796A1 (en) * 2010-06-03 2013-04-10 Mahmut Bilgic Formulations comprising calcium, vitamin d and vitamin k for osteoporosis
RU2606767C2 (ru) * 2011-05-20 2017-01-10 Фрисланд Брандз Б.В. Композиция, содержащая витамин k2
GB201203705D0 (en) * 2012-03-02 2012-04-18 Kappa Bioscience As Prodrugs

Also Published As

Publication number Publication date
AU2014304510A1 (en) 2016-02-18
AU2014304510B2 (en) 2017-03-16
EP3030319B1 (en) 2018-07-04
CN105492073A (zh) 2016-04-13
CN105492073B (zh) 2019-06-28
EP3030319A1 (en) 2016-06-15
US20160184254A1 (en) 2016-06-30
DK3030319T3 (en) 2018-08-06
WO2015018858A1 (en) 2015-02-12
HUE038719T2 (hu) 2018-11-28
GB201314245D0 (en) 2013-09-25

Similar Documents

Publication Publication Date Title
IL240290B (en) History of pyridazinone-amide and pharmaceutical preparations containing them
IL240863A0 (en) Amatoxin derivatives
IL240291A0 (en) History of pyridazinone and pharmaceutical preparations containing them
AP2015008869A0 (en) Benzimidazole derivatives as bromodomain inhibitors
IL244609B (en) History of 4-azaindole
ZA201602770B (en) Tyrosine derivatives and compositions comprising them
ZA201601333B (en) Oxoquinazolinyl-butanamide derivatives
ZA201602198B (en) Preparation of hydroxy-benzylbenzene derivatives
PL3022210T3 (pl) Nowy pochodne azabenzimidazolu
PL2993995T3 (pl) Proszkowy preparat z witaminą E
HUE038719T2 (hu) K-vitamin származékokat és sókat tartalmazó készítmények
SG11201605189YA (en) Imidazopyrazinone derivatives
SG11201507957VA (en) Stabilized vitamin d formulations
EP2968274A4 (en) MEROPENE DERIVATIVES AND USES THEREOF